64th ASH Annual Meeting & Exposition

Share on: 

Research coauthored by RTI Health Solutions researchers will be presented at the 64th ASH Annual Meeting & Exposition.

Fitusiran reaches people's with hemophilia and their caregivers' treatment expectations: qualitative semi-structured interviews of participants of ATLAS-OLE trial. Srivastava A, Rangarajan S, Reuben RC, Slota C, DiBenedetti D, Cano V, Andersson S, DasMahapatra P, Bartelt-Hofer J, Afonso M.
Poster Number: 3565
Program: Oral and Poster Abstracts
Session: 904. Outcomes Research—Non-Malignant Conditions: Poster II
Time and Location: Sunday, December 11, 2022: 6:00 PM-8:00 PM

Patients with hemophilia and their caregivers prefer treatment attributes that enable a more active lifestyle with lower risk of inhibitor development. Cano V, Mansfield C, Pierce A, Leach C, Smith JC, DasMahapatra P, Bartelt-Hofer J. Poster

Understanding patient preferences for chronic lymphocytic leukemia treatments. Ravelo A, Myers K, Brumble R, Bussberg C, Koffman B, Manzoor BS, Biondo J, Mansfield C. Poster 

Clinical burden of β-Thalassemia: findings from a multinational medical record abstraction study. Cappellini MD, Yucel A, Meyers J, Jimenez M, Nham T, Glassberg MB, Alashkar F. Poster